PURPOSE: Currently, no instruments are available to assess symptoms secondary to lymphedema in patients with head and neck cancer (HNC). The study aim was to develop and conduct preliminary tests of such an instrument. METHODS: A preliminary item pool was generated from a literature review, previous work in breast cancer-related lymphedema, and an observational study. The item pool was revised based on an expert panel's suggestions and feedback from 18 patients with HNC. The current questionnaire, the Lymphedema Symptom Intensity and Distress Survey-Head and Neck (LSIDS-H&N), was then pilot tested in 30 patients with HNC. RESULTS: Preliminary testing (1) demonstrated feasibility, readability, and ease of use of the LSIDS-H&N and (2) identified that there was a considerable level of symptom burden in the cohort of patients in the piloting sample. CONCLUSION: Content validity of the LSIDS-H&N was supported by the expert panel during development of the LSIDS-H&N. Further testing is ongoing.
PURPOSE: Currently, no instruments are available to assess symptoms secondary to lymphedema in patients with head and neck cancer (HNC). The study aim was to develop and conduct preliminary tests of such an instrument. METHODS: A preliminary item pool was generated from a literature review, previous work in breast cancer-related lymphedema, and an observational study. The item pool was revised based on an expert panel's suggestions and feedback from 18 patients with HNC. The current questionnaire, the Lymphedema Symptom Intensity and Distress Survey-Head and Neck (LSIDS-H&N), was then pilot tested in 30 patients with HNC. RESULTS: Preliminary testing (1) demonstrated feasibility, readability, and ease of use of the LSIDS-H&N and (2) identified that there was a considerable level of symptom burden in the cohort of patients in the piloting sample. CONCLUSION: Content validity of the LSIDS-H&N was supported by the expert panel during development of the LSIDS-H&N. Further testing is ongoing.
Authors: Thomas Zimmermann; Henry Leonhardt; S Kersting; S Albrecht; U Range; Uwe Eckelt Journal: Biol Trace Elem Res Date: 2005-09 Impact factor: 3.738
Authors: Oliver Micke; Frank Bruns; Ralph Mücke; Ulrich Schäfer; Michael Glatzel; Alexander F DeVries; Klaus Schönekaes; Klaus Kisters; Jens Büntzel Journal: Int J Radiat Oncol Biol Phys Date: 2003-05-01 Impact factor: 7.038
Authors: Jie Deng; Barbara A Murphy; Mary S Dietrich; Robert J Sinard; Kyle Mannion; Sheila H Ridner Journal: Support Care Cancer Date: 2015-08-29 Impact factor: 3.603
Authors: Joseph M Aulino; Elizabeth M Wulff-Burchfield; Mary S Dietrich; Sheila H Ridner; Kenneth J Niermann; Jie Deng; Bethany A Rhoten; Jennifer K Doersam; Lee Ann Jarrett; Kyle Mannion; Barbara A Murphy Journal: Lymphat Res Biol Date: 2018-02 Impact factor: 2.589
Authors: Jennifer K Doersam; Mary S Dietrich; Melissa A Adair; Bethany Rhoten; Jie Deng; Sheila H Ridner Journal: Lymphat Res Biol Date: 2019-08-05 Impact factor: 2.589
Authors: Louise Marie Beelen; Anne-Margreet van Dishoeck; Elena Tsangaris; Michelle Coriddi; Joseph H Dayan; Andrea L Pusic; Anne Klassen; Dalibor Vasilic Journal: Ann Surg Oncol Date: 2020-11-28 Impact factor: 5.344